| Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy V Goede, O Coutelle, J Neuneier, A Reinacher-Schick, R Schnell, ... British journal of cancer 103 (9), 1407-1414, 2010 | 193 | 2010 |
| Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 … S Kubicka, R Greil, T André, J Bennouna, J Sastre, E Van Cutsem, ... Annals of oncology 24 (9), 2342-2349, 2013 | 122 | 2013 |
| Expression of platelet-derived growth factor-C and insulin-like growth factor I in hepatic stellate cells is inhibited by miR-29 M Kwiecinski, N Elfimova, A Noetel, U Töx, HM Steffen, U Hacker, ... Laboratory investigation 92 (7), 978-987, 2012 | 109 | 2012 |
| Engineering the AAV capsid to optimize vector–host-interactions H Büning, A Huber, L Zhang, N Meumann, U Hacker Current opinion in pharmacology 24, 94-104, 2015 | 102 | 2015 |
| Regorafenib in combination with FOLFOX or FOLFIRI as first-or second-line treatment of colorectal cancer: results of a multicenter, phase Ib study B Schultheis, G Folprecht, J Kuhlmann, R Ehrenberg, UT Hacker, ... Annals of oncology 24 (6), 1560-1567, 2013 | 101 | 2013 |
| Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis. UT Hacker, M Gomolka, E Keller, A Eigler, C Folwaczny, H Fricke, E Albert, ... Gut 40 (5), 623-627, 1997 | 77 | 1997 |
| Embelin inhibits endothelial mitochondrial respiration and impairs neoangiogenesis during tumor growth and wound healing O Coutelle, HT Hornig‐Do, A Witt, M Andree, LM Schiffmann, M Piekarek, ... EMBO molecular medicine 6 (5), 624-639, 2014 | 75 | 2014 |
| Adeno‐associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiency UT Hacker, L Wingenfeld, DM Kofler, NK Schuhmann, S Lutz, T Herold, ... The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2005 | 75 | 2005 |
| In vivo synthesis of tumor necrosis factor-α in healthy humans after live yellow fever vaccination UT Hacker, T Jelinek, S Erhardt, A Eigler, G Hartmann, HD Nothdurft, ... The Journal of infectious diseases 177 (3), 774-778, 1998 | 75 | 1998 |
| Spontaneous and cationic lipid-mediated uptake of antisense oligonucleotides in human monocytes and lymphocytes G Hartmann, A Krug, M Bidlingmaier, U Hacker, A Eigler, R Albrecht, ... Journal of Pharmacology and Experimental Therapeutics 285 (2), 920-928, 1998 | 74 | 1998 |
| Ubiquitin C-terminal hydrolase-L1 potentiates cancer chemosensitivity by stabilizing NOXA K Brinkmann, P Zigrino, A Witt, M Schell, L Ackermann, P Broxtermann, ... Cell reports 3 (3), 881-891, 2013 | 71 | 2013 |
| Improved Killing of Ovarian Cancer Stem Cells by Combining a Novel Chimeric Antigen Receptor–Based Immunotherapy and Chemotherapy R Klapdor, S Wang, U Hacker, H Büning, M Morgan, T Dörk, P Hillemanns, ... Human gene therapy 28 (10), 886-896, 2017 | 66 | 2017 |
| Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours MR Weihrauch, H Richly, MS von Bergwelt-Baildon, HJ Becker, ... European journal of cancer 51 (2), 146-156, 2015 | 63 | 2015 |
| Characterization of a novel third-generation anti-CD24-CAR against ovarian cancer R Klapdor, S Wang, M Morgan, T Dörk, U Hacker, P Hillemanns, H Büning, ... International journal of molecular sciences 20 (3), 660, 2019 | 59 | 2019 |
| Adrenaline enhances LPS-induced IL-10 synthesis: evidence for protein kinase A-mediated pathway B Siegmund, A Eigler, G Hartmann, U Hacker, S Endres International journal of immunopharmacology 20 (1-3), 57-69, 1998 | 58 | 1998 |
| Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial UT Hacker, L Escalona-Espinosa, N Consalvo, V Goede, L Schiffmann, ... British Journal of Cancer 114 (8), 855-862, 2016 | 56 | 2016 |
| Tropism-modified AAV vectors overcome barriers to successful cutaneous therapy J Sallach, G Di Pasquale, F Larcher, N Niehoff, M Rübsam, A Huber, ... Molecular Therapy 22 (5), 929-939, 2014 | 55 | 2014 |
| Randomised phase II trial to investigate catumaxomab (anti-EpCAM× anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer M Knödler, J Körfer, V Kunzmann, J Trojan, S Daum, M Schenk, ... British journal of cancer 119 (3), 296-302, 2018 | 50 | 2018 |
| Influence of the IL-1Ra gene polymorphism on in vivo synthesis of IL-1Ra and IL-1β after live yellow fever vaccination UT Hacker, S Erhardt, K Tschöp, T Jelinek, S Endres Clinical & Experimental Immunology 125 (3), 465-469, 2001 | 47 | 2001 |
| Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial UT Hacker, D Hasenclever, N Linder, G Stocker, HC Chung, YK Kang, ... Journal of cachexia, sarcopenia and muscle 11 (1), 135-144, 2020 | 41 | 2020 |
